Table: begin end state 1 29 non-cytoplasmic 30 50 transmembrane 51 59 cytoplasmic 60 80 transmembrane 81 91 non-cytoplasmic 92 114 transmembrane 115 119 cytoplasmic 120 138 transmembrane 139 159 non-cytoplasmic 160 180 transmembrane 181 191 cytoplasmic 192 210 transmembrane 211 232 non-cytoplasmic 233 254 transmembrane 255 265 cytoplasmic 266 290 transmembrane 291 311 non-cytoplasmic 312 336 transmembrane 337 365 cytoplasmic 366 384 transmembrane 385 389 non-cytoplasmic 390 410 transmembrane 411 421 cytoplasmic 422 442 transmembrane 443 447 non-cytoplasmic 448 467 transmembrane 468 474 cytoplasmic
Input: >WP_036136365.1 NCBI__GCF_000768355.1:WP_036136365.1 MLQRLLATKHPHAAHADADGLSLHRTLGKWGLTALGIGAVIGGGIFVITGQAAADHAGPA IMLSFVLAAICCTFCALAYAEFASMVPVSGSAYTYTYATLGELAAWFIGWMLVLEYGVSA SAVAVSWTGYFLSLLEHFNIHLPAALVQAPLDSKLQPTGAIANLPAAAIVLLLTWVCYIG IRKSSGMNTAMVLLKSGLIVLVIIAGWQYVDPANWEPFIPANEGPGKFGWEGVLRGASMV FFAYIGFEAVSVAAQESHNPQKDLPFGMLMSLAICTVLYIGMAAVMTGLTPYTLLGTDEP VVTAVAGHAELAWLRVVVEIGALIGLSSVVLVMIIGQPRIFMIMARDGLLPEVFTRIHPK HRTPHINTVITGIGIALLAAVFPLDILGELTSMGTLIAFGAVCAGVLILRRTQPDLPRPF RIRGVWFVCLAGIFSCLALLSAMTLHNWMLMLGWTTVGFAIYFLYGYRHSKLKG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server